+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Qutenza"

Capsaicin Pain Relief Patch Market Report 2025 - Product Thumbnail Image

Capsaicin Pain Relief Patch Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Post Surgical Pain Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Post Surgical Pain Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Qutenza is a topical analgesic patch used to treat neuropathic pain. It is a transdermal patch containing 8% capsaicin, a chemical derived from chili peppers. The patch is applied to the skin and works by blocking the transmission of pain signals to the brain. It is approved for use in adults with postherpetic neuralgia, a condition caused by shingles. It is also used to treat other types of neuropathic pain, such as diabetic neuropathy and HIV-related neuropathy. Qutenza is manufactured by Astellas Pharma Inc. and marketed in the United States by Endo Pharmaceuticals. It is also available in other countries, including Canada, the United Kingdom, and Australia. Companies in the Qutenza market include Astellas Pharma Inc., Endo Pharmaceuticals, Pfizer, GlaxoSmithKline, and Novartis. Show Less Read more